[1] |
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I.,etal. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA:ACancerJournalforClinicians, 74, 229-263. https://doi.org/10.3322/caac.21834 |
[2] |
Muzi, M., Peterson, L.M., Specht, J.M., Hippe, D.S., Novakova-Jiresova, A., Lee, J.H.,etal. (2024) Repeatability of 18F-FDG Uptake in Metastatic Bone Lesions of Breast Cancer Patients and Implications for Accrual to Clinical Trials.EJNMMI Research, 14, Article No. 32. https://doi.org/10.1186/s13550-024-01093-7 |
[3] |
Coleman, R.E. (2006) Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity.Clinical Cancer Research, 12, 6243s-6249s. https://doi.org/10.1158/1078-0432.ccr-06-0931 |
[4] |
王如良, 张少华. 乳腺癌骨转移和骨相关疾病临床诊疗研究进展[J]. 中国医药, 2022, 17(7): 1111-1115. |
[5] |
刘沫含, 周星彤, 孙强. 乳腺癌骨转移研究进展——从基础到临床[J]. 协和医学杂志, 2023, 14(3): 638-645. |
[6] |
李娜, 屈辉. 骨转移瘤的影像学诊断进展[J]. 中国医学影像技术, 2006(1): 159-162. |
[7] |
陈凤, 崔亚利. 骨转移瘤影像学检查研究概述[J]. 医学综述, 2019, 25(1): 134-138+143. |
[8] |
陈丽媚. 全身骨显像联合单光子发射计算机断层扫描/计算机断层扫描融合显像诊断乳腺癌骨转移的临床应用价值分析[J]. 大医生, 2023, 8(23): 112-114. |
[9] |
Wu, Q., Yang, R., Zhou, F. and Hu, Y. (2013) Comparison of Whole-Body MRI and Skeletal Scintigraphy for Detection of Bone Metastatic Tumors: A Meta-Analysis.Surgical Oncology, 22, 261-266. https://doi.org/10.1016/j.suronc.2013.10.004 |
[10] |
Iagaru, A. and Minamimoto, R. (2018) Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer.PET Clinics, 13, 383-393. https://doi.org/10.1016/j.cpet.2018.02.002 |
[11] |
Hamaoka, T., Madewell, J.E., Podoloff, D.A., Hortobagyi, G.N. and Ueno, N.T. (2004) Bone Imaging in Metastatic Breast Cancer.Journal of Clinical Oncology, 22, 2942-2953. https://doi.org/10.1200/jco.2004.08.181 |
[12] |
余学军, 李玲玲. 全身骨显像和单光子发射计算机断层显像/CT局部断层融合显像在肺癌骨转移诊断中的应用[J]. 实用医学影像杂志, 2023, 24(6): 452-454. |
[13] |
Janicek, M. and Shaffer, K. (1995) Scintigraphic and Radiographic Patterns of Skeletal Metastases in Breast Cancer: Value of Sequential Imaging in Predicting Outcome.Skeletal Radiology, 24, 597-600. https://doi.org/10.1007/bf00204859 |
[14] |
饶良俊, 王晓燕, 陈志丰, 罗炳棋, 张祥松, 史新冲, 易畅. 对比分析~(99m)Tc-MDP SPECT与~(18)F-NaF PET/CT术前诊断肺癌骨转移的价值[J]. 中国医学影像技术, 2012, 28(12): 2233-2238. |
[15] |
朱焓钰, 黄晓红, 石野宽, 游金辉. ~(18)F-NaF PET/CT在骨骼疾病诊断中的应用与研究进展[J]. 安徽医学, 2024, 45(3): 376-379. |
[16] |
Ahmed, N., Sadeq, A., Marafi, F., Gnanasegaran, G. and Usmani, S. (2022) Therapy-Induced Bone Changes in Oncology Imaging with18F-Sodium Fluoride (NaF) PET-CT.Annals of Nuclear Medicine, 36, 329-339. https://doi.org/10.1007/s12149-022-01730-y |
[17] |
Refaat, R., Abd Alkhalik Basha, M., Sobhi Hassan, M., Hussein, R.S., Al-Molla, R.M., Awad, N.M.,etal. (2019) Is FDG Maximum Standardized Uptake Value of Primary Breast Cancer a Prognostic Factor for Locoregional Axillary Lymph Node Metastasis?Acta Radiologica, 60, 1241-1250. https://doi.org/10.1177/0284185118824770 |
[18] |
王禾, 张亚男. PET及PET/CT在乳腺癌骨转移早期诊断中应用的研究进展[J]. 东南大学学报(医学版), 2021, 40(1): 129-132. |
[19] |
石庆学, 许欣茹, 郭佳, 左峰, 张宗鹏, 张国旭, 王治国. ~(18)F-NaF PET/CT显像与~(99m)Tc-MDP SPECT骨显像对乳腺癌患者骨转移诊断的对比研究[J]. 中国临床医学影像杂志, 2021, 32(1): 40-43. |
[20] |
何婷婷, 施彦坤, 苑克慧, 黄江山, 李哲成, 胡蓉蓉, 李群, 王卉. ~(18)F-氟化钠PET-CT显像中低剂量CT在骨转移病变中的诊断价值[J]. 中国医学装备, 2017, 14(7): 76-79. |
[21] |
Eubank, W.B., Lee, J.H. and Mankoff, D.A. (2009) Disease Restaging and Diagnosis of Recurrent and Metastatic Disease Following Primary Therapy with FDG-PET Imaging.PET Clinics, 4, 299-312. https://doi.org/10.1016/j.cpet.2009.09.001 |
[22] |
罗焱文, 朱庆莉. 乳腺癌影像组学研究进展[J]. 协和医学杂志, 2021, 12(6): 983-988. |
[23] |
许阿磊. 精准定量SPECT/CT在乳腺癌骨转移诊断和疗效评估方面的应用[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2020. |
[24] |
Fan, Z., Wang, T., Zou, L. and Liu, D. (2023) Comparison of the Diagnostic Value of18F-NaF PET/CT and99mTc-MDP SPECT for Bone Metastases: A Systematic Review and Meta-Analysis.Translational Cancer Research, 12, 3166-3178. https://doi.org/10.21037/tcr-23-817 |
[25] |
Ikeda, T., Kitajima, K., Tsuchitani, T.,etal. (2022) Effectiveness of Quantitative Bone SPECT/CT for Bone Metastasis Diagnosis.Hellenic Journal of Nuclear Medicine, 25, 253-259. |
[26] |
宋宏涛, 罗诗雨, 王磊. SPECT/CT在骨显像骨外放射性分布异常诊断中的增益价值[J]. 标记免疫分析与临床, 2023, 30(6): 927-931+941. |
[27] |
Sharma, P., Singh, H., Kumar, R., Bal, C., Thulkar, S., Seenu, V.,etal. (2012) Bone Scintigraphy in Breast Cancer: Added Value of Hybrid SPECT-CT and Its Impact on Patient Management.Nuclear Medicine Communications, 33, 139-147. https://doi.org/10.1097/mnm.0b013e32834e3b14 |
[28] |
王东, 孟宪平, 陈则君, 靳激扬. SPECT/CT融合图像与全身骨显像对骨转移瘤诊断的价值分析[J]. 中国CT和MRI杂志, 2016, 14(4): 126-129. |
[29] |
刘洁. SPECT/CT融合显像在肿瘤骨转移诊断中的增益价值[D]: [硕士学位论文]. 上海: 上海交通大学, 2016. |
[30] |
Chakraborty, S., Chatterjee, S., Chakravarty, R., Sarma, H.D., Nanabala, R., Goswami, D.,etal. (2024) Synthesis, Quality Control, and Bench-to-Bed Translation of a New [68Ga]Ga-Labeled Nota-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography.Cancer Biotherapy and Radiopharmaceuticals, 39, 92-101. https://doi.org/10.1089/cbr.2023.0077 |